Key result
Atropine reduces R-R interval variability during apnea, suggesting non-baroreflex modulation of respiratory sinus arrhythmia.
Why the study?
The role of autonomic regulation and the baroreflex in generating respiratory sinus arrhythmia has remained under dispute for decades.
Does autonomic blockade with atropine and propranolol alter cardiovascular oscillations and their interactions compared to saline in human subjects?
Does autonomic blockade with atropine and propranolol alter cardiovascular oscillations and their interactions compared to saline in human subjects?
Atropine-induced reduction in R-R interval power during apnea suggests respiratory sinus arrhythmia is modulated by mechanisms other than the baroreflex, and coherent respiratory oscillations in blood pressure may serve as a non-invasive measure of autonomic regulation.
Answers are grounded in this paper and cite their sources.
No immediate practice change in autonomic assessment; leaves open non-baroreflex modulation of respiratory sinus arrhythmia.
For decades the role of autonomic regulation and the baroreflex in the generation of the respiratory sinus arrhythmia (RSA) - modulation of heart rate by the frequency of breathing - has been under dispute. We hypothesized that by using autonomic blockers we can reveal which oscillations and their interactions are suppressed, elucidating their involvement in RSA as well as in cardiovascular regulation more generally. R-R intervals, end tidal CO 2 , finger arterial pressure, and muscle sympathetic nerve activity (MSNA) were measured simultaneously in 7 subjects during saline, atropine and propranolol infusion. The measurements were repeated during spontaneous and fixed-frequency breathing, and apnea. The power spectra, phase coherence and couplings were calculated to characterise the variability and interactions within the cardiovascular system. Atropine reduced R-R interval variability ( p < 0.05) in all three breathing conditions, reduced MSNA power during apnea and removed much of the significant coherence and couplings. Propranolol had smaller effect on the power of oscillations and did not change the number of significant interactions. Most notably, atropine reduced R-R interval power in the 0.145–0.6 Hz interval during apnea, which supports the hypothesis that the RSA is modulated by a mechanism other than the baroreflex. Atropine also reduced or made negative the phase shift between the systolic and diastolic pressure, indicating the cessation of baroreflex-dependent blood pressure variability. This result suggests that coherent respiratory oscillations in the blood pressure can be used for the non-invasive assessment of autonomic regulation.
No takes yet. Share an insight, caveat, or question.
Clemson et al. (2022) studied this question. Atropine and propranolol vs. Saline was evaluated on R-R interval variability (p=<0.05). Atropine infusion reduced R-R interval variability and MSNA power during apnea, suggesting respiratory sinus arrhythmia is modulated by mechanisms other than the baroreflex.
Synapse has enriched 10 related papers. Consider them for comparative context: